It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease.
https://arctichealth.org/en/permalink/ahliterature166035
Source
J Nucl Cardiol. 2006 Nov;13(6):761-7
Publication Type
Article
Date
Nov-2006
More detail
Author
Sharmila Dorbala
Alita Hassan
Therese Heinonen
Heinrich R Schelbert
Marcelo F Di Carli
Author Affiliation
Division of Nuclear Medicine/PET, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA. sdorbala@partners.org
Source
J Nucl Cardiol. 2006 Nov;13(6):761-7
Date
Nov-2006
Language
English
Publication Type
Article
Keywords
Adenosine - diagnostic use
Adolescent
Adult
Aged
Canada - epidemiology
Coronary Artery Disease - epidemiology - radionuclide imaging
Double-Blind Method
Female
Fractional Flow Reserve, Myocardial
Humans
Incidence
Longitudinal Studies
Male
Middle Aged
Positron-Emission Tomography - statistics & numerical data
Prognosis
Risk Assessment - methods
Risk factors
United States - epidemiology
Vasodilator Agents - diagnostic use
Abstract
The relationship between coronary vasodilator reserve and risk of coronary heart disease (CHD) in subjects without coronary artery disease (CAD) is not well known.
We studied 289 subjects (mean age, 58 +/- 10 years) without overt CAD and at low (
PubMed ID
17174807
View in PubMed
Less detail
Permalink